PLYX Polaryx Therapeutics, Inc. - Common Stock
$3.14
价格 · 五月 20, 2026
截至...的财报数据 五月 15, 2026
PLYX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$3.14
市值
—
P/E (TTM)
—
每股收益 (TTM)
$-0.20
营收 (TTM)
—
股息收益率
—
ROE
-193.7%
负债/权益
—
52周区间
$2 – $49
PLYX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-0.20
2024-12-31
→
2025-12-31
自由现金流
—
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
PLYX
同行中位数
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
PLYX
同行中位数
ROA
-176.7%
—
ROE
-193.7%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
PLYX
同行中位数
Current Ratio (流动比率)
8.5
—
Quick Ratio (速动比率)
8.5
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
PLYX
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
PLYX
同行中位数
PLYX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 2 28.6%
- 买入 4 57.1%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-05-15
最低
$10.00
最高
$10.00
中位数目标
$10.00
+218.5%
平均目标
$10.00
+218.5%
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PLYX | — | — | — | — | -193.7% | — |
| CNTX | $135M | -3.9 | 112.7% | — | -50.5% | — |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| ASRT | $58M | -1.9 | -5.0% | -25.6% | -32.4% | — |
| NTHI | — | -2.6 | -51.8% | — | — | — |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 11
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $6M | $3M | |
| SG&A Expense | $2M | $2M | |
| Operating Expenses | $8M | $4M | |
| Operating Income | $-8M | $-4M | |
| Pretax Income | $-9M | $-30M | |
| Net Income | $-9M | $-30M | |
| EPS (Basic) | $-0.20 | $-0.89 | |
| EPS (Diluted) | $-0.20 | $-0.89 | |
| Shares (Basic) | 45,422,581 | 34,200,660 | |
| Shares (Diluted) | 45,422,581 | 34,200,660 | |
| EBITDA | $-8M | · |
资产负债表 15
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $5M | $5M | |
| Prepaid Expense | · | $380.0K | |
| Other Current Assets | $27.0K | · | |
| Current Assets | $5M | $5M | |
| Total Assets | $5M | $5M | |
| Accounts Payable | $470.0K | $72.0K | |
| Accrued Liabilities | $23.0K | · | |
| Current Liabilities | $605.0K | $289.0K | |
| Total Liabilities | $605.0K | $289.0K | |
| Common Stock | $5.0K | $4.0K | |
| Paid-in Capital | $104M | $95M | |
| Retained Earnings | $-100M | $-91M | |
| Stockholders' Equity | $5M | $5M | |
| Liabilities + Equity | $5M | $5M | |
| Shares Outstanding | 47,343,297 | 41,151,571 |
现金流 5
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $5M | $2M | |
| Operating Cash Flow | $-4M | $-3M | |
| Stock Issued | $4M | $7M | |
| Net Stock Activity | $4M | · | |
| Financing Cash Flow | $4M | $7M |
盈利能力 2
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| ROA | -176.7% | · | |
| ROE | -193.7% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 8.5 | · | |
| Quick Ratio | 8.5 | · |
估值 (TTM) 1
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-9M | · |
损益表 10
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| R&D Expense | $679.0K | |
| SG&A Expense | $1M | |
| Operating Expenses | $2M | |
| Operating Income | $-2M | |
| Net Income | $-3M | |
| EPS (Basic) | $-0.05 | |
| EPS (Diluted) | $-0.05 | |
| Shares (Basic) | 47,219,329 | |
| Shares (Diluted) | 47,219,329 | |
| EBITDA | $-2M |
资产负债表 15
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $3M | |
| Prepaid Expense | $389.0K | |
| Other Current Assets | $33.0K | |
| Current Assets | $4M | |
| Total Assets | $4M | |
| Accounts Payable | $850.0K | |
| Accrued Liabilities | $45.0K | |
| Current Liabilities | $1M | |
| Total Liabilities | $1M | |
| Common Stock | $5.0K | |
| Paid-in Capital | $105M | |
| Retained Earnings | $-102M | |
| Stockholders' Equity | $2M | |
| Liabilities + Equity | $4M | |
| Shares Outstanding | 47,343,297 |
现金流 2
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Stock-based Comp | $467.0K | |
| Operating Cash Flow | $-2M |
盈利能力 2
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| ROA | -145.3% | |
| ROE | -204.5% |
流动性与偿付能力 2
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Current Ratio | 3.5 | |
| Quick Ratio | 3.0 |
估值 (TTM) 4
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Market Cap | $358M | |
| P/B | 143.9 | |
| P / Tangible Book | 143.9 | |
| P / Cash Flow | -173.5 |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| 净收入 | $-9M | $-30M |
| 稀释后每股收益 (EPS) | $-0.20 | $-0.89 |
资产负债表
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| 流动比率 | 8.5 | — |
| 速动比率 | 8.5 | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。